EPO and Alzheimer disease: Several studies have shown that the induction of adult hippocampal neurogenesis by various agents, such as erythropoietin [44,45], fluoxetine [46], brain-derived neurotrophic factor [47], curcumin [48], and selenomethionine [49], among others, have become promising treatment strategies for AD [49,50,51,52].